Literature DB >> 10320132

Five-year efficacy of intravenous gammaglobulin to treat dysautonomia in Sjögren's syndrome.

J L Dupond, H Gil, B de Wazieres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10320132

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

Review 1.  [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2004-08       Impact factor: 1.214

2.  Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.

Authors:  Bum-Su Choung; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2010-03-17       Impact factor: 2.631

3.  Immunoglobulin-responsive dysautonomia in Sjögren's syndrome.

Authors:  Yusuf A Rajabally; Hanny Seow; Richard J Abbott
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

Review 4.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

5.  Dry Eye Syndrome and Sicca Complex are Commonly Found in Patients with Postural Orthostatic Tachycardia Syndrome.

Authors:  Dave S Ho; Okeanis E Vaou; Anna D Hohler
Journal:  Clin Ophthalmol       Date:  2020-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.